Evidence-based overview of genomic medicine in Aotearoa and internationally, exploring key concepts and contemporary ethical, legal, social and cultural considerations associated with its adoption into healthcare.
This is an inter-professional paper that will be evidence based, Aotearoa focussed and underpinned by the ethos of "skills for next Monday". It is designed for clinical professionals, health scientists and researchers who want to develop knowledge and skills in the area of genomic medicine as it applies to healthcare.
|Paper title||Special Topic: Genomic Health and Medicine|
|Teaching period||Not offered in 2023 (Distance learning)|
|Domestic Tuition Fees (NZD)||$3,018.75|
|International Tuition Fees||Tuition Fees for international students are elsewhere on this website.|
- HASX 401
- Limited to
- MHealSc, PGDipHealSc, PGDipPHC
- Clinical experience is not required.Enrolments for this paper require departmental permission. View more information about departmental permission.
- Teaching staff
Sara Filoche and Michelle Thunders will be leading the paper, with input from nationwide experts in the field.
- Paper Structure
Through case studies and problem-based learning we will review the use of genomic technology in New Zealand healthcare - including ethical, legal, cultural and social considerations.
- Teaching Arrangements
Online and workshops
To be advised.
- Graduate Attributes Emphasised
Global perspective, Interdisciplinary perspective, Communication, Critical thinking, Cultural understanding, Ethics, Information literacy, Lifelong learning, Self-motivation.
View more information about Otago's graduate attributes.
- Learning Outcomes
Students who successfully complete this paper will
- Demonstrate an understanding and apply knowledge of genomics as they relate to healthcare
- Demonstrate an understanding and apply knowledge of ethical, social, cultural and legal considerations as they relate to genomics relevant to healthcare
- Critically be able to evaluate, identify and discuss future opportunities and challenges of the use of genomics relevant to healthcare